Continuous Wound Infiltration versus placebo following elective minimally invasive colorectal surgery; a double-blinded, randomised, placebo-controlled, low-intervention trial (CIMICS trial)
Phase 1
- Conditions
- Recovery following elective minimally invasive colorectal surgery, Recovery following elective minimally invasive colorectal surgeryTherapeutic area: Diseases [C] - Digestive System Diseases [C06]
- Registration Number
- CTIS2024-512107-39-00
- Lead Sponsor
- Catharina Ziekenhuis Stichting
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 192
Inclusion Criteria
18 years or older, Scheduled for minimally invasive colorectal surgery, Provided written informed consent
Exclusion Criteria
Any contra-indication to the CWI system or allergies for the used local analgesic, Inflammatory Bowel Disease: ulcerative colitis or Crohn’s disease, Emergency surgery, Chronic opioid consumption (i.e. daily use for at least 90 days), or active drug addiction
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method